drugset / Trial / NCT02892812
A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults
RandomizedParallel-groupSingle-blindPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of LBVE013 (Pneumococcal 13-valent conjugate vaccine \[diphtheria CRM197 protein\]) or LBVE014 (Pneumococcal 14-valent conjugate vaccine \[diphtheria CRM197 protein\]) in healthy adults.
Timeline
- Start
- 2016-09
- Primary completion
- 2016-11
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LBVE013 | Vaccine | — | Intramuscular |
| Subject | LBVE014 | Vaccine | — | Intramuscular |
| Subject | Prevnar 13 | Vaccine | — | Intramuscular |